Regarding “In-stent restenosis after carotid artery stenting is asymptomatic because of low embolic potential”  by Gallerini, Simone et al.
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Regarding “Bedside vena cava filter placement with
intravascular ultrasound: A simple, accurate, single
venous access method”
Jacobs et al1 present a single-puncture venous access method
for bedside inferior vena cava filter placement that takes advantage
of the relationship between the filter delivery catheter and the
corresponding sheath available on some commercially available
filter placement kits. The essential steps involve using intravascular
ultrasound (IVUS) to guide sheath placement to a level just below
the lowest most renal vein, advancement of the filter delivery catheter
to the premeasured distance aligning the tip of the filter with the end
of the sheath, and then withdrawing the sheath in a “pin-pull” fashion
to allow deployment of the filter at the infrarenal level.
We have adopted this exact single-puncture technique as well
for bedside filter delivery. However, a cautionary note should be
placed here that for the single-puncture technique described by the
authors to work, predetermined marks on the filter delivery cath-
eter that indicate when the filter is at the end of the sheath and
when the filter is out of the sheath are essential.
The authors evaluated eight different filters and concluded
that three were ideally suited for this technique: the Trapease and
Optease filters (Cordis Corp, Miami Lakes, Fla) and the Günter-
Tulip filter (Cook Inc, Bloomington, Ind). The described single-
puncture technique works well for these three filters because of the
device-specific marks placed in the manufacturing process that
allow the operator to understand the interaction of the sheath and
delivery system. The authors state that these five other filters “can
all be placed with the alternative IVUS-guided techniques” but do
not provide other technical details.
To adapt the single-puncture technique to other filter devices,
it is essential to understand the relationship between the filter
delivery catheter and sheath. Our previously published technique,
described in the Journal of Vascular Surgery “Technical Notes” in
2005,2 involves a single-puncture approach that is more relevant to
filter delivery systems such as the Greenfield Vena Cava Filter
(Boston Scientific Corp, Natick, Mass) that do not have corre-
sponding marks on the filter delivery catheter, a technique that has
also evolved in our experience since this original description. The
steps are similar to those described by the authors up to the point
of guiding the end of the sheath with IVUS to a level just below the
lowest most renal vein. The difference is that in the absence of
marks on the filter delivery catheter, the sheath is then pulled back
over the IVUS probe a distance equivalent to the length that the
filter delivery catheter extends beyond the sheath. For the Green-
field filter system, this distance is approximately 7 cm. When the
filter delivery catheter is loaded into the sheath, the tip of the filter
will precisely align with the lowest most renal vein upon deploy-
ment.
In short, these techniques are variations of the same concept
and reinforce the importance of understanding the device compo-
nent relationships in order to achieve intended technical accuracy
for filter delivery. As bedside filters techniques continue to evolve,
the techniques described by the authors and in our previous
published “Technical Notes” continue to highlight the feasibility
and safety of filter placement using IVUS.
Marc A. Passman, MD
Section of Vascular Surgery and Endovascular Therapy
University of Alabama at Birmingham
Birmingham, Ala
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Reply
I appreciate the insightful comments of the readers above and
agree in their analysis that understanding the relationships of the
filter delivery catheter and the delivery sheath lengths is essential to
the accurate deployment of filters using the single-puncture tech-
nique we described. Their single puncture technique, as described
for the Greenfield filter system, is indeed essentially the same as the
technique described in our report. However, the need to know the
distance the filter extends beyond the end of the sheath, and adjusting
the placement of the sheath back to accommodate for that distance is
an incremental additional step not required with the filter systems that
have manufactured markings on the delivery catheter to indicate the
position of the filter relative to the delivery sheath.
I share the enthusiasm of the readers for intravascular
ultrasound-guided filter placement. Their adaptation of the
single-puncture technique to a wider variety of filter systems is
an important expansion of the options.
Donald L. Jacobs, MD
Department of Surgery
Division of Vascular Surgery
Saint Louis University
Saint Louis, Mo
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Regarding “In-stent restenosis after carotid artery
stenting is asymptomatic because of low embolic
potential”
We read with interest the study by Lal et al1 evaluating the
patterns of in-stent restenosis (ISR) after carotid artery stenting
(CAS). They developed an ultrasound classification of ISR based
on the length and distribution of lesions and they showed that type
IV ISR (defined as a diffuse 10 mm proliferative, extending
outside the stent) and a history of diabetes are predictors of need of
target lesion revascularization. In addition, all patients with reste-
nosis were asymptomatic during follow-up apart from ultrasono-
graphic types I to IV. This observation is in accordance with
previous studies and may be related to the etiopathogenesis of
restenosis (in-stent neointimal hyperplasia).2
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But why is neointimal hyperplasia a relatively asymptomatic
condition if compared with equal-grade atherosclerotic stenosis?
The answer may be the lower embolic potential and, to ascertain
this issue, we compared clinic and instrumental findings in these
groups of patients. Five patients (4 men, 1 woman; mean age, 72
years) with asymptomatic type IV ISR (70% stenosis, developed
6 months from the procedure) and 10 patients (7 men, 3
women; mean age, 74 years) with asymptomatic severe atheroscle-
rotic plaque (70% stenosis) underwent follow-up visits every 3
months for a year. During each visit, clinical assessment and
transcranial Doppler monitoring for emboli detection were per-
formed. A 2-MHz multichannel transcranial Doppler Multidop
X-4 device (DWL, Sipplingen, Germany) was used in all patients
for 1-hour insonation of the middle cerebral artery, bilaterally. The
parameters were chosen according to the recommendations of the
International Consensus Group on Microembolus detection, and
microembolic signals (MES) were identified according to current
guidelines.3
All patients with ISR were asymptomatic and showed no MES
during follow-up. The stenosis degree was stable during follow-up,
and no revascularization procedure was performed. Among 10
patients with severe atherosclerotic plaque, two have had an ipsi-
lateral carotid transient ischemic attack at 6 months of follow-up.
They both showed MES and were immediately revascularized
without periprocedural complications; a further two patients re-
mained asymptomatic but showed MES at 9 months and were
successfully revascularized. In all these patients, MES were de-
tected in the middle cerebral artery ipsilateral to the stenotic
carotid artery but not in the contralateral one.
These results suggest that ISR, generally attributed to neoin-
timal hyperplasia, is associated with a low embolic load and then
with a low risk of cerebrovascular complications. As for asymptom-
atic carotid stenosis due to atherosclerosis, instead, the risk of
cerebrovascular events seems related to the presence of MES as
surrogate markers of plaque destabilization.4-6 Thus transcranial
Doppler monitoring for emboli detection may be a powerful tool
to select high-risk patients for early revascularization procedure.
Simone Gallerini, MD
Alberto Chiti, MD
Nicola Morelli, MD
Giovanni Orlandi, MD
Department of Neuroscience
Clinic of Neurology
Pisa, Italy
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Reply
Thank you for your interest in our article relating patterns of
in-stent restenosis (ISR) after carotid artery stenting (CAS) to
long-term outcomes.1 As stated by you, the key finding was that
the type of ISR and diabetes were independent predictors of future
high-grade ISR necessitating revascularization after CAS.
We agree with you that neointimal hyperplasia is associated
with a reduced potential for atheroembolization. As you have
observed, our results support this view. All our patients developed
high-grade ISR early during the course of their follow-up (24
months), which was likely due to neointimal hyperplasia. None of
these patients presented with atheroembolic neurologic complica-
tions. The reason for reintervening on these patients was the
preocclusive nature of the lesions and the inability of any testing
modality to predict which of these lesions would proceed to carotid
occlusion with subsequent stroke.
Risk stratification by measuring embolic signals with transcra-
nial Doppler has been intensively analyzed with conflicting results
till date. Studies have demonstrated a strong correlation with risk
for future stroke2 and, conversely, no correlation with risk for
subsequent stroke.3 A consensus has still not been reached on the
clinical utility or accuracy of this approach.4 The overarching
theme of all these studies, however, was that TCD was hypothe-
sized to be of utility in primary atherosclerotic carotid stenosis and
not in recently recurrent carotid stenosis that is likely the result of
neointimal hyperplasia. We appreciate the results of your study,
which confirm that intimal hyperplastic lesions carry a low poten-
tial for embolization. It is less likely that TCD will find utility in risk
stratification for the treatment of in-stent restenosis.
The current study1 was undertaken as an attempt to predict
which low-grade recurrent stenoses will progress to high-grade
lesions. Our results indicate that diffuse proliferative (type IV) ISR
lesions and diabetes are important and independent predictors of
progression and reintervention.
Thank you.
Brajesh K. Lal, MD
UMDNJ-New Jersey Medical School
Newark, NJ
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Regarding “Endovascular repair of para-anastomotic
aortic aneurysms”
Sachdev et al reported their experience of endovascular repair of
para-anastomotic aortic aneurysms (PAAA).1 We note that they state
that “Predictors of type I endoleaks include short, angulated aortic
necks, which are characteristic of proximal para-anastomotic aneu-
rysms of the infrarenal aorta” after open repair. Such infrarenal neck
anatomy can be inadequate to achieve a proximal seal with a standard
infrarenal device. Transrenal device fixation used in a short neck does
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